Allograft inflammatory factor-1 governs hematopoietic stem cell differentiation into CDC1 and monocyte-derived dendritic cells through IRF8 and RelB in vitro

Diana M. Elizondo, Nailah Z.D. Brandy, Ricardo L.L. Da Silva, Naomi L. Haddock, Apollo D. Kacsinta, Tatiana R. De Moura, Michael W. Lipscomb

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

The multistep differentiation process from hematopoietic stem cells through common myeloid progenitors into committed dendritic cell (DC) subsets remains to be fully addressed. These studies now show that Allograft Inflammatory Factor-1 (AIF1) is required for differentiation of classical DC type 1 (cDC1) subsets and monocyte-derived DC (Mo-DC). Phenotypic studies found that AIF1 expression increased in committed subsets differentiating from common myeloid progenitors (CMP). However, silencing AIF1 expression in hematopoietic stem progenitors restrained the capacity to differentiate into Mo-DC and cDC1 cell subsets under GM-CSF or Flt3-L stimuli conditions, respectively. This was further marked by restrained expression of IRF8, which is critical for development of Mo-DC and cDC1 subsets. As a result, absence of AIF1 restrained the cells at the LinCD117+FcγR−CD34+ CMP stage. Further biochemical studies revealed that abrogating AIF1 resulted in inhibition of the NFκB family member RelB expression and p38 MAPK phosphorylation during differentiation of Mo-DC. Lastly, protein binding studies identified that AIF1 interacts with protein kinase C (PKC) to influence downstream signaling pathways. Taken together, this is the first report showing a novel role of AIF1 as a calcium-responsive scaffold protein that supports IRF8 expression and interacts with PKC to drive NFκB-related RelB for successfully differentiating hematopoietic progenitor cells into cDC and Mo-DC subsets under Flt3-L and GM-CSF stimuli, respectively.

Original languageEnglish (US)
Article number173
JournalFrontiers in immunology
Volume10
Issue numberFEB
DOIs
StatePublished - 2019
Externally publishedYes

Bibliographical note

Funding Information:
Grant Support: This work was funded, in part, by the U.S. National Institutes of Health (grant# SC1GM127207), Department of Defense (grant# W911NF-14-1-0123), and National Science Foundation (grant# 1428768).

Publisher Copyright:
© 2019 Elizondo, Brandy, da Silva, Haddock, Kacsinta, de Moura and Lipscomb. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Keywords

  • Allograft inflammatory factor 1
  • CDC1 dendritic cells
  • Dendritic cells
  • Hematopoietic stem cells
  • IRF8 transcriptional coactivator
  • Monocyte-derived DC
  • Protein kinase C (PKC)
  • RelB/NFκB

Fingerprint

Dive into the research topics of 'Allograft inflammatory factor-1 governs hematopoietic stem cell differentiation into CDC1 and monocyte-derived dendritic cells through IRF8 and RelB in vitro'. Together they form a unique fingerprint.

Cite this